Salmeterol xinafoate bulk supplier for pharma manufacturers

Salmeterol Xinafoate 25 µg, 50 µg Suppliers & Bulk Manufacturers

Available Forms: Inhalation

Available Strengths: 25 µg, 50 µg

Reference Brands: Serevent (USA/LATAM/EU)

Salmeterol Xinafoate is a Respiratory Disorder product available as Inhalation in strengths 25 µg, 50 µg. It corresponds to the reference brand Serevent (USA/LATAM/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Salmeterol Xinafoate? List it or send an offer →

Product Description:

Salmeterol xinafoate is a long-acting β2-adrenergic receptor agonist (LABA) used for the treatment and prevention of asthma symptoms and for the long-term management of chronic obstructive pulmonary disease (COPD). It works by relaxing the smooth muscles in the airways, which helps to open the bronchi and improve airflow, making it easier to breathe. Salmeterol is effective in controlling symptoms such as shortness of breath, wheezing, coughing, and chest tightness associated with bronchospasm.

In addition to chronic management, salmeterol is also used to prevent breathing difficulties triggered by exercise, known as exercise-induced bronchoconstriction. Its long-acting nature provides sustained bronchodilation, typically lasting up to 12 hours, which allows for twice-daily dosing as part of a maintenance therapy plan.

Salmeterol is generally administered via inhalation using dry powder inhalers or metered-dose inhalers and is often combined with inhaled corticosteroids to optimize asthma control. While highly effective for symptom management, it is not intended for immediate relief of acute asthma attacks, and patients are advised to use a short-acting bronchodilator for sudden symptoms. Its targeted action makes it an essential therapy in the management of chronic respiratory conditions.

Salmeterol Xinafoate — third party manufacturing & bulk supply

Salmeterol Xinafoate 25 µg, 50 µg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Salmeterol Xinafoate is supplied as Inhalation — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Salmeterol Xinafoate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Salmeterol Xinafoate →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Salmeterol xinafoate is used as a long-term maintenance treatment for asthma and COPD. It helps relax airway smooth muscles, prevents bronchospasms, and improves airflow. Salmeterol is not intended for immediate relief of acute asthma attacks.

Salmeterol xinafoate is a synthetic long-acting β2-adrenergic agonist that stimulates beta-2 receptors in the airway smooth muscles, causing relaxation and prolonged bronchodilation, improving respiratory function in chronic lung diseases.

Common trade names include Serevent and Seretide (when combined with fluticasone).

Serevent and Seretide are marketed by GlaxoSmithKline.

The generic name of Serevent is salmeterol xinafoate.

Well-known brand names include Serevent and Seretide (combination).

Salmeterol inhalers and combination products are manufactured in GMP-certified facilities in Europe, the United States, and other regulated regions, adhering to international quality and safety standards.